11 Years of the Fontan operation at a single institution: Results from 87 consecutive patients

Hebah S Al Absi1, Laszlo Kiraly2, Bassem Mora2

  • 1Department of Pediatrics, Sheikh Khalifa Medical City, Abu Dhabi, United Arab Emirates.

Insights

The Fontan operation, a key treatment for single ventricle patients, showed favorable early outcomes in a UAE tertiary center. This study reports a 6% mortality rate and highlights factors like heterotaxy impacting survival.

Area of Science:

  • Pediatric Cardiology
  • Congenital Heart Disease Surgery
  • Cardiovascular Surgery

Background:

  • The Fontan procedure is the standard surgical palliation for complex single-ventricle congenital heart defects.
  • Evaluating early outcomes is crucial for refining surgical techniques and patient management.

Purpose of the Study:

  • To assess early morbidity and mortality rates following the Fontan operation.
  • To identify potential risk factors influencing outcomes in a cohort of 87 patients.

Main Methods:

  • Retrospective analysis of 87 consecutive Fontan operations performed between 2007 and 2017.
  • Evaluation of early survival, intensive care unit (ICU) and hospital stay durations.
  • Analysis of preoperative and intraoperative variables for their impact on outcomes.

Main Results:

  • The Fontan procedure was performed at a median age of 4.2 years, with extracardiac Fontan being the preferred method.
  • Early survival was 94%, with an overall mortality rate of 6%.
  • Heterotaxy and decreased ventricular function were identified as significant risk factors for reduced survival.

Conclusions:

  • The Fontan operation demonstrated favorable early postoperative outcomes in a tertiary care center in the United Arab Emirates.
  • Reported mortality and morbidity rates are comparable to international benchmarks.
  • The findings support the feasibility of performing the Fontan procedure in this region.

Related Concept Videos